CERVIX | CERVICAL SCREENING [ISSN 1804-087X]
česky | english | sitemap


PARTNERS AND EXPERT GUARANTEE
 
Czech Gynaecological and Obstetrical Society | Ministry of Health | Institute of Biostatistics and Analyses, Masaryk University
GRANT SUPPORT OF THE PROJECT
 
GlaxoSmithKline     Roche |

Other sources of information
Cervical cytology (in Czech)www.cipek.cz
Cervical cytology
 
Cancer Screening in the European Unionec.europa.eu
Cancer Screening in the European Union (2017)
[ 10,6 MB]
 
SVOD - Epidemiology of malignant tumours in the Czech Republicwww.svod.cz
Epidemiology of malignant tumours
in the Czech Republic
 
NCI Bethesda System
HPV College

 

News

Archive

Year: 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008


Cervical cancer, a common cause of death in countries where no screening programmes are available
12.12.2013 IARC Press Release | More information...

The International Agency for Research on Cancer (IARC), the specialized cancer agency of the World Health Organization, today released the latest data on cancer incidence, mortality, and prevalence worldwide.

HPV testing could cut cervical cancers by a third
14.6.2013 Cancer Research UK Press Release | More information...

Testing women for the human papillomavirus (HPV) first, instead of using the traditional cervical screening test to detect abnormal cells in the cervix, could prevent around 600 cases of cervical cancer a year in England.

Cervical cancer: DNA-based test more accurate than repeat smear (“Pap”)
27.3.2013 | More information...

In women who have a potentially or mildly abnormal cervical smear, using a DNA-based test can identify those at higher risk of having precursors of cervical cancer, according to a new Cochrane systematic review. The authors found that the DNA-based test identified patients in possible need of treatment more accurately than a repeat smear test.

HPV vaccine trends point to failures in patient education, vaccine programs
14.3.2013 University of Texas Medical Branch at Galveston (UTMB) Press Resease | More information...

Completion rates for the human papillomavirus vaccine series across both genders continue to remain alarmingly low nearly seven years after its introduction, suggesting that better patient education and increased public vaccine financing programs are needed, according to new research from the University of Texas Medical Branch at Galveston.

Tackling tobacco consumption and improving vaccination access are two of the best ways to reduce global cancer burden
6.3.2013 Cancer Research UK Press Release | More information...

Combating the tobacco industry’s tactics in the world’s poorest countries as well as ensuring the best cancer vaccines are available to those most in need are key in order to reduce the number of cancer deaths worldwide, according to a new report published in the journal Science Translational Medicine, today (Wednesday).

1.5 million premature cancer deaths could be prevented per year if targets set to reduce NCDs are met by 2025
4.2.2013 UICC Press Release | More information...

The Union for International Cancer Control (UICC) and the International Agency for Research on Cancer (IARC) today announced that 1.5 million lives which would be lost to cancer, could be saved per year if decisive measures are taken to achieve the World Health Organization’s (WHO) ‘25 by 25’ target; to reduce premature deaths due to non-communicable diseases (NCDs) by 25% by 2025 (*).

Cervical smear tests 'could also detect ovarian and womb cancer'
10.1.2013 Cancer Research UK | More information...

DNA from cervical screening samples could also be used to detect ovarian and womb (endometrial) cancers, according to preliminary US research.


Back